Evidence map›Paper›PMID 42493359›Full record

ReviewImmunology2026

Aire and Fezf2 Shape the Medullary Thymic Epithelial Cell Immunopeptidome for Central Tolerance.

Geraldo Aleixo Passos, Vitor Marcel Faça, Eduardo Antonio Donadi, Ana Paula Masson, Carlos Crippa Coletto, Gustavo Ronconi Roza

Abstract readReview
In one paragraph

Review in Immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Geraldo Aleixo PassosLaboratory of Genetics and Molecular Biology, Department of Basic and Oral Biology, Ribeirão Preto School of Dentistry, University of São Paulo, Ribeirão Preto, Brazil.ORCID https://orcid.org/0000-0002-4408-140X
Vitor Marcel FaçaLaboratory of Cancer Proteomics, Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Eduardo Antonio DonadiDivision of Clinical Immunology, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Ana Paula MassonLaboratory of Cancer Proteomics, Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Carlos Crippa ColettoMolecular Immunogenetics Group, Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Gustavo Ronconi RozaMolecular Immunogenetics Group, Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 302828/2026-5Conselho Nacional de Desenvolvimento Científico e Tecnológico 303782/2024-2Conselho Nacional de Desenvolvimento Científico e Tecnológico 311304/2021-4Conselho Nacional de Desenvolvimento Científico e Tecnológico 316934/2021Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 001Fundação de Amparo à Pesquisa do Estado de São Paulo 2023/17154-2Fundação de Amparo à Pesquisa do Estado de São Paulo 2025/09892-9
6 · The paper itself

Abstract

Medullary thymic epithelial cells (mTECs) are central to immune self-tolerance owing to their capacity to express and present a diverse repertoire of self-derived peptides to developing thymocytes. This diversity arises from both promiscuous gene expression and specialised differentiation programmes, including thymic mimetic-cell populations, and is largely shaped by AIRE/Aire and FEZF2/Fezf2. Although the roles of Aire and Fezf2 in regulating peripheral tissue antigen transcription are well established, a critical conceptual gap remains regarding how transcriptional promiscuity is translated into the repertoire of peptides presented by major histocompatibility complex class II (MHC-II) molecules. In this review and perspective, we synthesize knowledge on mTEC biology, Aire- and Fezf2-dependent transcriptional programmes, and advances in immunopeptidomics. We discuss regulatory layers that decouple mRNA abundance from peptide presentation and highlight how single-cell transcriptomics and mass spectrometry-based immunopeptidomics provide complementary insights into mTEC heterogeneity and antigenic output. We argue that integrating these approaches is essential to understand central tolerance mechanistically and to explain selective defects in thymic self-antigen presentation. This framework offers a refined basis for interpreting autoimmune disease origins and guiding antigen-focused therapeutic strategies.

Indexed as

Central ToleranceEpithelial CellsThymus GlandTranscription FactorsTranscription Factors, TFIIAIRE ProteinAnimalsAntigen PresentationAutoantigensHumansPeptidesSelf ToleranceAIRE ProteinAutoantigensFEZF2 protein, humanPeptidesTranscription FactorsTranscription Factors, TFIIAirecentral toleranceFezf2immunopeptidomemTECpromiscuous gene expression

Identifiers

PMID42493359
PMCPMC13636128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.